AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29871327 — intervention group
Group type: COMPARATOR
Intervention: Anterior approach parotid gland region resection preserving retinal ganglion and parotid fascia
Number of subjects: 112
Study 26495319 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (target-controlled infusion)
Number of subjects: 31
Study 23090858 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational animation explaining how EGMs work
Number of subjects: 72
Study 23090858 — intervention group
Group type: EXPERIMENTAL
Intervention: Pop-up limit reminder
Number of subjects: 72
Study 23090858 — intervention group
Group type: COMPARATOR
Intervention: Neutral video (control)
Number of subjects: 72
Study 21338974 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo Wii™ group
Number of subjects: 22
Study 21338974 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 19211665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril therapy for 12 weeks
Number of subjects: 49
Study 19211665 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 49
Study 19211665 — intervention group
Group type: EXPERIMENTAL
Intervention: After 12-week treatment
Number of subjects: 49
Study 19211665 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate regression analysis
Number of subjects: 49
Study 16952598 — intervention group
Group type: EXPERIMENTAL
Intervention: Frenotomy
Number of subjects: 25
Study 16952598 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 25
Study 15552602 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose isotretinoin (13‐cis‐retinoic acid)
Number of subjects: 0
Study 15552602 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 11555064 — intervention group
Group type: EXPERIMENTAL
Intervention: Office-based recruitment strategy
Number of subjects: 188
Study 11555064 — intervention group
Group type: COMPARATOR
Intervention: Roster-based recruitment strategy
Number of subjects: 188
Study 9240534 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid MR imaging
Number of subjects: 62
Study 9240534 — intervention group
Group type: COMPARATOR
Intervention: Plain radiography
Number of subjects: 62
Study 8199827 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilutamide plus orchidectomy
Number of subjects: 1056
Study 8199827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1056
Study 3475201 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg three times a day for eight days
Number of subjects: 10
Study 3475201 — intervention group
Group type: COMPARATOR
Intervention: Placebo identical in appearance to ibuprofen
Number of subjects: 10
Study 30150437 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1 metronome-paced breathing during cellular phone exposure
Number of subjects: 20
Study 30150437 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:2 metronome-paced breathing during cellular phone exposure
Number of subjects: 20
Study 30150437 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exposure effect
Number of subjects: 20
Study 30150437 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 20
Study 29798336 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy and chemotherapy combined with cetuximab
Number of subjects: 78
Study 29798336 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy and diamminedichloroplatinum
Number of subjects: 78
Study 24471739 — intervention group
Group type: EXPERIMENTAL
Intervention: Convergence exercises independent of accommodation
Number of subjects: 156
Study 24471739 — intervention group
Group type: EXPERIMENTAL
Intervention: Accommodation exercises
Number of subjects: 156
Study 24471739 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined convergence and accommodation exercises
Number of subjects: 156
Study 24471739 — intervention group
Group type: COMPARATOR
Intervention: Placebo regime
Number of subjects: 156
Study 24471739 — intervention group
Group type: COMPARATOR
Intervention: Control group with maximum effort
Number of subjects: 156
Study 22052231 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary medical male circumcision (VMMC)
Number of subjects: 1344
Study 22052231 — intervention group
Group type: EXPERIMENTAL
Intervention: Being married or cohabitating
Number of subjects: 1344
Study 20122266 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and support programme for general practice teams, including multidisciplinary training sessions, integration of prompts in electronic medical records, and a direct referral pathway to a domestic violence advocate.
Number of subjects: 48
Study 20122266 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail in the abstract).
Number of subjects: 48
Study 17941869 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet alone, diet followed by metformin, or metformin alone
Number of subjects: 1084
Study 17941869 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 1084
Study 15852991 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 0.25 mg kg(‐1)
Number of subjects: 105
Study 15852991 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 0.5 mg kg(‐1)
Number of subjects: 105
Study 15852991 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.25 mg kg(‐1)
Number of subjects: 105
Study 15852991 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.5 mg kg(‐1)
Number of subjects: 105
Study 15852991 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 105
Study 15852991 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 105
Study 15852991 — intervention group
Group type: COMPARATOR
Intervention: Placebo (15 mg kg(‐1) acetaminophen)
Number of subjects: 105
Study 12578251 — intervention group
Group type: EXPERIMENTAL
Intervention: Easy visual degradation
Number of subjects: 150
Study 12578251 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium visual degradation
Number of subjects: 150
Study 12578251 — intervention group
Group type: COMPARATOR
Intervention: Hard visual degradation
Number of subjects: 150
Study 9524026 — intervention group
Group type: EXPERIMENTAL
Intervention: Phaco-emulsification with trabeculectomy (phaco-trab)
Number of subjects: 50
Study 9524026 — intervention group
Group type: COMPARATOR
Intervention: Extracapsular cataract extraction with trabeculectomy (ECCE-trab)
Number of subjects: 50
Study 7621311 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to conventional risk factors
Number of subjects: 0
Study 7621311 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 0
Study 2572137 — intervention group
Group type: EXPERIMENTAL
Intervention: Datex Relaxograph
Number of subjects: 0
Study 2572137 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0
Study 2572137 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 0
Study 2572137 — intervention group
Group type: EXPERIMENTAL
Intervention: New bolus-constant infusion regimen of atracurium
Number of subjects: 0
Study 5441886 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous secretin (2 units per kilogram per hour)
Number of subjects: 0
Study 5441886 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrajejunal acid infusion
Number of subjects: 0
Study 29695183 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus coagulans Unique IS2 chewable tablets
Number of subjects: 141
Study 29695183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 27040087 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (4-month cycloergometer training)
Number of subjects: 39
Study 27040087 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (intramuscular injection of testosterone undecylate for 4 months)
Number of subjects: 39
Study 27040087 — intervention group
Group type: EXPERIMENTAL
Intervention: Training + Testosterone
Number of subjects: 39
Study 27040087 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 39
Study 24893955 — intervention group
Group type: EXPERIMENTAL
Intervention: Light and intermittent smokers
Number of subjects: 41
Study 24893955 — intervention group
Group type: COMPARATOR
Intervention: Heavy smokers
Number of subjects: 41
Study 22551058 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intervention group (n = 200)
Number of subjects: 400
Study 22551058 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention group (n = 200)
Number of subjects: 400
Study 20180173 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance Training (BT)
Number of subjects: 20
Study 20180173 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 20
Study 18339788 — intervention group
Group type: COMPARATOR
Intervention: Neither primary caregiver nor day-care provider smoked
Number of subjects: 519
Study 18339788 — intervention group
Group type: EXPERIMENTAL
Intervention: Either primary caregiver or day-care provider smoked
Number of subjects: 519
Study 18339788 — intervention group
Group type: EXPERIMENTAL
Intervention: Both primary caregiver and day-care provider smoked
Number of subjects: 519
Study 18339788 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental perception of child's exposure
Number of subjects: 519
Study 18339788 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents reporting tobacco smoke exposure having small/no negative effect on child's asthma
Number of subjects: 519
Study 18339788 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents contemplating, preparing, or recently taking action to reduce child's exposure
Number of subjects: 519
Study 16019761 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical methods integrating molecular biomarkers with existing prognostic factors
Number of subjects: 0
Study 16019761 — intervention group
Group type: COMPARATOR
Intervention: Current staging system
Number of subjects: 0
Study 12752020 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-melancholic depressed patients
Number of subjects: 210
Study 12752020 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbid personality disorder
Number of subjects: 210
Study 11134978 — intervention group
Group type: EXPERIMENTAL
Intervention: Black currant anthocyanosides (BCA) 50 mg/subject
Number of subjects: 21
Study 11134978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 11134978 — intervention group
Group type: EXPERIMENTAL
Intervention: Black currant anthocyanosides (BCA)
Number of subjects: 21
Study 8916484 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of lipid disorders after angioplasty
Number of subjects: 0
Study 8916484 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 1397814 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits focusing on smoking, drug and nutrition education, support, and links with community services
Number of subjects: 154
Study 1397814 — intervention group
Group type: COMPARATOR
Intervention: Control group (no home visits)
Number of subjects: 154
Study 1397814 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (home visits)
Number of subjects: 154
Study 1397814 — intervention group
Group type: EXPERIMENTAL
Intervention: Family function screen
Number of subjects: 154
Study 1397814 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised equation involving history of previous premature birth, smoking, and low maternal weight-height ratio
Number of subjects: 154
Study 4056250 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 17
Study 4056250 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 17
Study 4056250 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (after histamine provocation)
Number of subjects: 17
Study 30561509 — intervention group
Group type: EXPERIMENTAL
Intervention: Alemtuzumab treatment
Number of subjects: 0
Study 30561509 — intervention group
Group type: EXPERIMENTAL
Intervention: CD20+ T cells in CSF
Number of subjects: 0
Study 30561509 — intervention group
Group type: EXPERIMENTAL
Intervention: CD20+ T cells in blood
Number of subjects: 0
Study 28217889 — intervention group
Group type: EXPERIMENTAL
Intervention: EBFT-home
Number of subjects: 183
Study 28217889 — intervention group
Group type: EXPERIMENTAL
Intervention: EBFT-office
Number of subjects: 183
Study 28217889 — intervention group
Group type: COMPARATOR
Intervention: Women's Health Education
Number of subjects: 183
Study 28217889 — intervention group
Group type: EXPERIMENTAL
Intervention: EBFT (both home and office)
Number of subjects: 183
Study 27555203 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-level ultrasound-guided TPVB (group S)
Number of subjects: 60
Study 27555203 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-level ultrasound-guided TPVB (group D)
Number of subjects: 60
Study 25322163 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral nail avulsion with phenolization (LNAP)
Number of subjects: 53
Study 25322163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve (nail tube splinting) method
Number of subjects: 53
Study 25322163 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 53
Study 22056537 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 69
Study 22056537 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 69
Study 22056537 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 69
Study 22056537 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D(3) supplementation
Number of subjects: 69
Study 22056537 — intervention group
Group type: EXPERIMENTAL
Intervention: Appendicular Lean Mass (aLM)
Number of subjects: 69
Study 22056537 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle Power
Number of subjects: 69
Study 22056537 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported functional deficits (SF-LLFDI)
Number of subjects: 69
Study 20602712 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol ER (100 to 250 mg bid)
Number of subjects: 1117
Study 20602712 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone CR (20 to 50 mg bid)
Number of subjects: 1117
Study 18047650 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy, exercise and advice with traction
Number of subjects: 30
Study 18047650 — intervention group
Group type: COMPARATOR
Intervention: Manual therapy, exercise and advice without traction
Number of subjects: 30
Study 16037865 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous suture technique
Number of subjects: 139
Study 16037865 — intervention group
Group type: COMPARATOR
Intervention: Interrupted suture technique
Number of subjects: 139
Study 11165735 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular fluid
Number of subjects: 23
Study 11165735 — intervention group
Group type: COMPARATOR
Intervention: Blood
Number of subjects: 23
Study 9330386 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive lymphadenectomy (n = 23)
Number of subjects: 248
Study 9330386 — intervention group
Group type: COMPARATOR
Intervention: Conventional lymphadenectomy (n = 22)
Number of subjects: 248
Study 9330386 — intervention group
Group type: EXPERIMENTAL
Intervention: Curative operation (RO)
Number of subjects: 248
Study 9330386 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-curative operation (R1 and R2)
Number of subjects: 248
Study 9330386 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall operative death rate
Number of subjects: 248
Study 7892983 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy for 24 hours followed by continuation for 3 days (Group 1)
Number of subjects: 83
Study 7892983 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy for 3 days (Group 3)
Number of subjects: 83
Study 7892983 — intervention group
Group type: COMPARATOR
Intervention: Discontinued oxygen after Day 1 (Group 2)
Number of subjects: 83
Study 7892983 — intervention group
Group type: COMPARATOR
Intervention: No oxygen therapy (Group 4)
Number of subjects: 83
Study 3034541 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV hyperimmunoglobulin (CMV-Polyglobin) administered intravenously at 2 ml/kg bodyweight at three-week intervals up to day 105 after kidney transplantation
Number of subjects: 100
Study 3034541 — intervention group
Group type: COMPARATOR
Intervention: Control group (no infusions)
Number of subjects: 100
Study 3034541 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV hyperimmunoglobulin (CMV-Polyglobin) administered intravenously
Number of subjects: 100
Study 2169833 — intervention group
Group type: EXPERIMENTAL
Intervention: +sotalol (400 mg every 12 h)
Number of subjects: 8
Study 2169833 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg every 12 h)
Number of subjects: 8
Study 2169833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1097478 — intervention group
Group type: EXPERIMENTAL
Intervention: Penfluridol, administered in a dosage of 40 to 80 mg once a week
Number of subjects: 0
Study 1097478 — intervention group
Group type: COMPARATOR
Intervention: Neuroleptics requiring daily administration
Number of subjects: 0
Study 31655592 — intervention group
Group type: EXPERIMENTAL
Intervention: Night on call or overnight shift (Group A before night)
Number of subjects: 260
Study 31655592 — intervention group
Group type: EXPERIMENTAL
Intervention: Night on call or overnight shift (Group A after night)
Number of subjects: 260
Study 31655592 — intervention group
Group type: COMPARATOR
Intervention: Night on call or overnight shift (Group B after night)
Number of subjects: 260
Study 31655592 — intervention group
Group type: COMPARATOR
Intervention: Night on call or overnight shift (Group B before night)
Number of subjects: 260
Study 27139812 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation-induced blood flow
Number of subjects: 33
Study 27139812 — intervention group
Group type: COMPARATOR
Intervention: Blood-flow restriction
Number of subjects: 33
Study 27139812 — intervention group
Group type: COMPARATOR
Intervention: Passive rest
Number of subjects: 33
Study 27139812 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 33
Study 25805118 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) over 6 weeks plus routine care (RC)
Number of subjects: 308
Study 25805118 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive Counselling (SC) plus routine care (RC)
Number of subjects: 308
Study 25805118 — intervention group
Group type: COMPARATOR
Intervention: Routine Care (RC) alone
Number of subjects: 308
Study 24274342 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arrest therapeutic hypothermia (IATH) using trans nasal evaporative cooling (TNEC) during CPR
Number of subjects: 0
Study 24274342 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment including therapeutic hypothermia initiated after hospital admission
Number of subjects: 0
Study 21555501 — intervention group
Group type: EXPERIMENTAL
Intervention: CLON‐XR plus stimulant
Number of subjects: 198
Study 21555501 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus stimulant
Number of subjects: 198
Study 19002433 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 800
Study 19002433 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 EE90 (2 g/day)
Number of subjects: 800
Study 19002433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study 16672406 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam
Number of subjects: 156
Study 16672406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 14871280 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy (rabeprazole 20 mg b.d. + amoxicillin 1 g b.d. for 5 days, followed by rabeprazole 20 mg b.d. + tinidazole 500 mg b.d. + clarithromycin 500 mg b.d. for 5 days)
Number of subjects: 96
Study 14871280 — intervention group
Group type: COMPARATOR
Intervention: Prolonged triple therapy (rabeprazole 20 mg b.d. + amoxicillin 1 g b.d. + clarithromycin 500 mg b.d. for 10 days)
Number of subjects: 96
Study 11341166 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin-docetaxel (DD)
Number of subjects: 33
Study 11341166 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin-cyclophosphamide (DC)
Number of subjects: 33
Study 9109229 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy given preoperatively
Number of subjects: 0
Study 9109229 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy and chemotherapy given preoperatively
Number of subjects: 0
Study 9109229 — intervention group
Group type: COMPARATOR
Intervention: Surgical resection
Number of subjects: 0
Study 8197612 — intervention group
Group type: EXPERIMENTAL
Intervention: 2x 100 mg/day CsA from day 0
Number of subjects: 164
Study 8197612 — intervention group
Group type: EXPERIMENTAL
Intervention: 2x 200 mg/day CsA from day 4
Number of subjects: 164
Study 8197612 — intervention group
Group type: EXPERIMENTAL
Intervention: 2x 300 mg/day CsA from day 4
Number of subjects: 164
Study 3070179 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular emulsified disulfiram (1 g in soybean emulsion)
Number of subjects: 5
Study 3070179 — intervention group
Group type: COMPARATOR
Intervention: Oral disulfiram
Number of subjects: 5
Study 3070179 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular emulsified disulfiram
Number of subjects: 5
Study 31162810 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 80
Study 31162810 — intervention group
Group type: COMPARATOR
Intervention: ADA guidelines diet
Number of subjects: 80
Study 29516705 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (0.1 µg/kg/min)
Number of subjects: 0
Study 29516705 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine (0.4 µg/kg/h)
Number of subjects: 0
Study 28373674 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone/bupropion (NB)
Number of subjects: 2046
Study 28373674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2046
Study 25048646 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondrug, nonoperative interventions (e.g., weight loss, shoe orthoses)
Number of subjects: 591
Study 25048646 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondrug, nonoperative interventions (e.g., strengthening exercises, stretching exercises)
Number of subjects: 591